Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • The Health Equity podcast
    • Access insights
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Date

09 December 2020

The threat of antibiotic resistance — in charts

Andrew Jack and Chris Campbell for the Financial Times look at government and nonprofit efforts to track antibiotic overuse and antimicrobial resistance.

Direct links

Read the full article

In this article, the authors compile data from the Access to Medicine Foundation, the Centre for Disease Dynamics, Economics and Policy (CDDEP), Pew Charitable Trusts, and The Farm Animal Investment Risk & Return initiative (FAIRR) to highlight the challenges created by antibiotic overuse both in humans and in animals farmed for food. The authors illustrate the issues with the use of charts and graphs from these organisations.

The authors note that while efforts to measure trends in antibiotic use have been historically limited, programmes such as the Access to Medicine Foundation's Antimicrobial Resistance Benchmark, along with other government and nonprofit initiatives, work to track antibiotic usage and encourage action against antimicrobial resistance.

The authors write that the Foundation's Antimicrobial Resistance Benchmark "tracks the activities of pharmaceutical companies on antimicrobial resistance, providing a tool for investors and policymakers." They quote the Benchmark report, noting that “the pace of change in 2020 does not match the scale of the AMR challenge”.

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved